127 related articles for article (PubMed ID: 8951976)
1. Evaluation of stearate-graphite paste electrodes for chronic measurement of extracellular dopamine concentrations in the mammalian brain.
Blaha CD
Pharmacol Biochem Behav; 1996 Nov; 55(3):351-64. PubMed ID: 8951976
[TBL] [Abstract][Full Text] [Related]
2. Does monoamine oxidase inhibition by pargyline increase extracellular dopamine concentrations in the striatum?
Blaha CD; Coury A; Phillips AG
Neuroscience; 1996 Nov; 75(2):543-50. PubMed ID: 8931017
[TBL] [Abstract][Full Text] [Related]
3. Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
Hefti F; Melamed E
Brain Res; 1981 Nov; 225(2):333-46. PubMed ID: 7306794
[TBL] [Abstract][Full Text] [Related]
4. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.
Zetterström T; Sharp T; Collin AK; Ungerstedt U
Eur J Pharmacol; 1988 Apr; 148(3):327-34. PubMed ID: 3384000
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of the properties of a multifiber carbon electrode allowing long-term electrochemical detection of dopamine in freely moving animals.
el Ganouni S; Forni C; Nieoullon A
Brain Res; 1987 Feb; 404(1-2):239-56. PubMed ID: 3494483
[TBL] [Abstract][Full Text] [Related]
6. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.
Imperato A; Di Chiara G
J Neurosci; 1984 Apr; 4(4):966-77. PubMed ID: 6716134
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway.
Andrés ME; Gysling K; Bustos G
Brain Res; 1998 Jun; 797(2):255-66. PubMed ID: 9666143
[TBL] [Abstract][Full Text] [Related]
9. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
Santiago M; Westerink BH
J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
[TBL] [Abstract][Full Text] [Related]
10. Voltammetry in the striatum of chronic freely moving rats: detection of catechols and ascorbic acid.
Gonon F; Buda M; Cespuglio R; Jouvet M; Pujol JF
Brain Res; 1981 Oct; 223(1):69-80. PubMed ID: 7284811
[TBL] [Abstract][Full Text] [Related]
11. Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat.
Borland LM; Shi G; Yang H; Michael AC
J Neurosci Methods; 2005 Aug; 146(2):149-58. PubMed ID: 15975664
[TBL] [Abstract][Full Text] [Related]
12. In vivo selective monitoring of basal levels of cerebral dopamine using voltammetry with Nafion modified (NA-CRO) carbon fibre micro-electrodes.
Crespi F; Möbius C
J Neurosci Methods; 1992 May; 42(3):149-61. PubMed ID: 1501500
[TBL] [Abstract][Full Text] [Related]
13. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.
Miele M; Mura MA; Enrico P; Esposito G; Serra PA; Migheli R; Zangani D; Miele E; Desole MS
Br J Pharmacol; 2000 Feb; 129(3):582-8. PubMed ID: 10711358
[TBL] [Abstract][Full Text] [Related]
14. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
15. Effects of triadimefon on extracellular dopamine, DOPAC, HVA and 5-HIAA in adult rat striatum.
Gagnaire F; Micillino JC
Toxicology; 2006 Jan; 217(2-3):91-104. PubMed ID: 16246478
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
Synapse; 1990; 6(1):106-12. PubMed ID: 1697988
[TBL] [Abstract][Full Text] [Related]
17. Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.
Yoshitake T; Kehr J; Yoshitake S; Fujino K; Nohta H; Yamaguchi M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):177-83. PubMed ID: 15203027
[TBL] [Abstract][Full Text] [Related]
18. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
19. Microdialysis studies of D-amphetamine-evoked striatal dopamine overflow in young versus aged F344 rats: effects of concentration and order of administration.
Purdom MS; Stanford JA; Currier TD; Gerhardt GA
Brain Res; 2003 Jul; 979(1-2):203-9. PubMed ID: 12850587
[TBL] [Abstract][Full Text] [Related]
20. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
